Short- and long-term consequences of prenatal exposure to cannabis;Conséquences à court et long terme d'une exposition prénatale au cannabis

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 35, Issue 1, 2006, Pages 62-70

  Karila, L ^a   Cazas, O ^a   Danel, T ^b   Reynaud, M ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b Clinique de la Charite   (France)

Author keywords

Cannabis; Cognitive deficits; Fetal development; Marijuana; Neurobehavioral deficits; Pregnancy; Prenatal exposure

Indexed keywords

ALCOHOL; CANNABINOID; CANNABIS;

ATTENTION; ATTENTION DEFICIT DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CHILD BEHAVIOR; CIGARETTE SMOKING; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; DATA BASE; FETUS DEVELOPMENT; GROWTH; HEALTH PROGRAM; HUMAN; IMPULSIVENESS; INFORMATION RETRIEVAL; LANGUAGE; LEARNING DISORDER; LOW BIRTH WEIGHT; MEDICAL INFORMATION; MEDLINE; MEMORY; MEMORY DISORDER; NEWBORN DISEASE; PERINATAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PREVENTIVE MEDICINE; REPRODUCTION; REVIEW; SMOKING;

EID: 32144454419     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(06)76373-6     Document Type: Review

References (59)

1. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 2002; 78: 610-24.
2. Koob GF. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 2000; 909: 170-85.
3. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-52.
4. Karila L, Martelli C, Benyamina A, Lukasiewicz M, Alter C, Rahioui H et al. Mécanismes neurobiologiques des addictions : une revue de la littérature. Synapse 2004 ; 206 : 13-9.
5. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999; 58: 315-48.
6. Park B, Gibbons HM, Mitchell MD, Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003; 24: 990-5.
7. Gardner EL. Addictive potential of cannabinoids: the underlying neurobiology. Chem Phys Lipids 2002; 121: 267-90.
8. Park B, JM McPartland, Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 189-97.
9. OMS. Classification Internationale des Maladies. Critères diagnostiques pour la recherche. Dixième révision. CIM-10/ICD-10. Trad. par CB Pull. Masson, éd. Masson, Paris, 1994.
10. DSM-IV: Text Revision - Manuel diagnostique et statistique des troubles mentaux, éd. Masson, Paris, 2005.
11. Hurd YL, Wang X, Anderson V, Beck O, Minkoff H, Dow-Edwards D. Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol 2005; 27: 221-9.
12. OFDT. Drogues et dépendances. Indicateurs et tendances. Paris, 2002, 368 p.
13. INSERM. Expertise collective cannabis : quels effets sur le comportement et la santé ? éd. INSERM, Paris, 2001, 429 p.
14. Asch RH, Smith CG. Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J Reprod Med 1986; 31: 1071-81.
15. Abel EL, Dintcheff BA, Day N. Effects of marihuana on pregnant rats and their offspring. Psychopharmacology (Berl) 1980; 71: 71-4.
16. Banerjee, BN, Galbreath C, Sofia RD. Teratologic evaluation of synthetic delta-9-tetrahydrocannabinol in rats. Teratology 1975; 11: 99-101.
17. Fried PA. Short and long-term effects of pre-natal cannabis inhalation upon rat offspring. Psychopharmacology (Berl) 1976; 50: 285-91.
18. Navarro M, Rubio P, de Fonseca FR. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology (Berl) 1995; 122: 1-14.
19. Huizink AC, Mulder EJ. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2005; sous presse.
20. Persaud TV, Ellington AC. Cannabis in early pregnancy. Lancet 1967; 2: 1306.
21. Neuberg R. Drug dependence and pregnancy: a review of the problems and their management. J Obstet Gynaecol Br Commonw 1970; 77: 1117-22.
22. Harbison RD, Mantilla-Plata B. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 1972; 180: 446-53.
23. Greenland S, Staisch KJ, Brown N, Gross SJ. Effects of marijuana on human pregnancy, labor, and delivery. Neurobehav Toxicol Teratol 1982; 4: 447-50.
24. Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 1984; 150: 23-7.
25. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320: 762-8.
26. Idanpaan-Heikkila J, Fritchie GE, Englert LF, Ho BT, McIsaac WM. Placental transfer of tritiated-1-delta-9-tetrhydrocannabinol. N Engl J Med 1969; 281: 330.
27. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42: 327-60.
28. Kuczkowski KM. Marijuana in pregnancy. Ann Acad Med Singapore 2004; 33: 336-9.
29. Hingson R, Alpert JJ, Day N, Dooling E, Kayne H, Morelock S. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics, 1982; 70: 539-46.
30. Fergusson DM, Horwood LJ, Northstone K. Maternal use of cannabis and pregnancy outcome. Bjog 2002; 109: 21-7.
31. Day NL, Richardson GA. Prenatal marijuana use: epidemiology, methodologic issues, and infant outcome. Clin Perinatol 1991; 18: 77-91.
32. English DR, Hulse GK, Milne E, Holman CD, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997; 92: 1553-60.
33. Fried PA, O'Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol Teratol, 1987; 9: 79-85.
34. Hurd YL, Wang X, Anderson V, Beck O, Minkoff H, Dow-Edwards D. Marijuana impairs growth in mid-gestation fetuses. Neurotoxol Teratol 2005; 27: 221-9.
35. Scragg RK, Mitchell EA, Ford RP, Thompson JM, Taylor BJ, Stewart AW. Maternal cannabis use in the sudden death syndrome. Acta Paediatr 2001; 90: 57-60.
36. Fried PA, Watkinson B, Grant A, Knights RM. Changing patterns of soft drug use prior to and during pregnancy: a prospective study. Drug Alcohol Depend 1980; 6: 323-43.
37. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22: 325-36.
38. Fried PA. Marihuana use by pregnant women: neurobehavioral effects in neonates. Drug Alcohol Depend 1980; 6: 415-24.
39. Fried PA. Marihuana use by pregnant women and effects on offspring: an update. Neurobehav Toxicol Teratol 1982; 4: 451-4.
40. Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23: 1-11.
41. Leech SL, Richardson GA, Goldschmidt L, Day NL. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol 1999; 21: 109-18.
42. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 2002; 24: 309-20.
43. Goldschmidt L, Richardson GA, Cornelius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004; 26: 521-32.
44. Fried PA, Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2001; 23: 421-30.
45. Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2003; 25: 427-36.
46. Mamen M. Effects of marijuana on young adults. Cmaj 2002; 167: 233; author reply 234.
47. Porath AJ, Fried PA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol 2005; 27: 267-77.
48. Booth JR, Burman DD, Meyer JR, Lei Z, Trommer BL, Davenport ND et al. Neural developement of selective attention and response inhibition. Neuroimage 2003; 20: 737-51.
49. Creutzfeld OD. Coretx cerebri: performance, structural and functionnal organization of the cortex. Oxford University Press, Oxford, 1995.
50. Van Eden CG, Buijs RM. Functional neuroanatomy of the prefrontal cortex: autonomic interactions. Prog Brain Res 2000; 126: 49-62.
51. Lewis DA. Images in neuroscience. Neural networks: neural systems IV: prefrontal cortex. Am J Psychiatry 2000; 157: 1752.
52. Smith A, Fried P, Hogan M, Cameron I. The effects of prenatal and current marijuana exposure on response inhibition: a functional magnetic resonance imaging study. Brain Cogn 2004; 54: 147-9.
53. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 2004; 26: 533-42.
54. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004; 47(Suppl 1): 3-13.
55. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129.
56. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482-97.
57. Wang X, Dow-Edwards D, Anderson V, Minkoff H, Hurd YL. In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol Psychiatry 2004; 56: 909-15.
58. Wang X, Dow-Edwards D, Keller E, Hurd YL. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience 2003; 118: 681-94.
59. Gray KA, Richardson G, Day N. Prenatal marijuana use and child depression at age ten. Neurotox Teratol 1997; 19: 245.